EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, WVE: Wave Life Sci Ord Sh

24 Mar 26 09:19
LAST:

11.56

CHANGE:
 0.06		OPEN:
11.52		HIGH:
12.09		ASK:
36.00		VOLUME:
7.5K
CHG(%):
0.52		PREV:
11.62		LOW:
11.52		BID:
20.15		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Mar 2611.5212.0911.5211.567.5K
23 Mar 2612.1112.1211.4211.623.81M
20 Mar 2612.0512.2411.6511.765.82M
19 Mar 2611.7412.4011.5212.122.3M
18 Mar 2612.3312.5711.7911.902.95M
17 Mar 2612.4012.6512.2612.462.15M
16 Mar 2613.1213.3812.3812.412.61M
13 Mar 2613.4213.6512.5813.022.83M
12 Mar 2613.7914.0413.2113.351.81M
11 Mar 2613.7914.3213.5614.081.79M

PROFILE

Name:Wave Life Sci Ord Sh
About:Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, an RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-N531, an exon skipping oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.
Sector:Healthcare
Industry:Biotechnology
Address:Marina One East Tower, Singapore, Singapore, 018936
Website:https://wavelifesciences.com
CUSIP:Y95308105
CIK:0001631574
ISIN:USY953081053
FIGI:BBG00B642V54

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-11.87 
Forward P/E:-12.77 
PEG Ratio:-0.49 
Price to Sales:15.32 
Price to Book:19.86 
Profit Margin:-1.38 
Operating Margin:-6.07 
Return on Assets:-0.39 
Return on Equity:-1.71 
EPS Ratio:-0.65 
Revenue:93.95M 
Shares:185.76M 
Market Cap:2.147B 

TECHNICAL INDICATORS

MA5:11.792.0%
MA10:12.437.5%
MA20:13.1213.5%
MA50:13.3115.2%
MA100:12.568.6%
MA200:10.1713.7%
RSI14:26.68 
WPR14:-100.00 
MTM14:-1.64
ROC14:-0.12 
ATR:0.78 
Week High:12.659.5%
Week Low:11.421.2%
Month High:15.4733.8%
Month Low:11.4213.7%
Year High:21.7388.0%
Year Low:5.28118.9%
Volatility:10.09